LFPI Stock Overview
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
LifePoint, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 3 Year Change | -99.99% |
| 5 Year Change | 0% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| LFPI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | -3.7% |
| 1Y | 0% | 2.5% | 20.2% |
Return vs Industry: LFPI matched the US Healthcare industry which returned 0.8% over the past year.
Return vs Market: LFPI underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| LFPI volatility | |
|---|---|
| LFPI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LFPI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LFPI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | M. Wadley | www.lifepointinc.org |
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998.
LifePoint, Inc. Fundamentals Summary
| LFPI fundamental statistics | |
|---|---|
| Market cap | US$102.00 |
| Earnings (TTM) | -US$14.55m |
| Revenue (TTM) | US$81.90k |
0.0x
P/S Ratio0.0x
P/E RatioIs LFPI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFPI income statement (TTM) | |
|---|---|
| Revenue | US$81.90k |
| Cost of Revenue | US$2.61m |
| Gross Profit | -US$2.53m |
| Other Expenses | US$12.02m |
| Earnings | -US$14.55m |
Last Reported Earnings
Dec 31, 2004
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did LFPI perform over the long term?
See historical performance and comparison